- Home
- HOOK vs CCTG Comparison
HOOK vs CCTG Comparison
Compare HOOK & CCTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOOK
- CCTG
- Stock Information
- Founded
- HOOK 2011
- CCTG 1993
- Country
- HOOK United States
- CCTG Hong Kong
- Employees
- HOOK N/A
- CCTG N/A
- Industry
- HOOK Biotechnology: Pharmaceutical Preparations
- CCTG
- Sector
- HOOK Health Care
- CCTG
- Exchange
- HOOK Nasdaq
- CCTG Nasdaq
- Market Cap
- HOOK 11.9M
- CCTG 12.5M
- IPO Year
- HOOK 2019
- CCTG 2024
- Fundamental
- Price
- HOOK $0.89
- CCTG $1.09
- Analyst Decision
- HOOK Hold
- CCTG
- Analyst Count
- HOOK 3
- CCTG 0
- Target Price
- HOOK $4.50
- CCTG N/A
- AVG Volume (30 Days)
- HOOK 155.2K
- CCTG 4.2K
- Earning Date
- HOOK 08-11-2025
- CCTG 08-23-2025
- Dividend Yield
- HOOK N/A
- CCTG N/A
- EPS Growth
- HOOK N/A
- CCTG N/A
- EPS
- HOOK N/A
- CCTG N/A
- Revenue
- HOOK $9,351,000.00
- CCTG $17,631,489.00
- Revenue This Year
- HOOK N/A
- CCTG N/A
- Revenue Next Year
- HOOK N/A
- CCTG N/A
- P/E Ratio
- HOOK N/A
- CCTG N/A
- Revenue Growth
- HOOK N/A
- CCTG 19.55
- 52 Week Low
- HOOK $0.72
- CCTG $0.99
- 52 Week High
- HOOK $6.00
- CCTG $3.17
- Technical
- Relative Strength Index (RSI)
- HOOK 19.78
- CCTG 49.55
- Support Level
- HOOK $0.89
- CCTG $1.06
- Resistance Level
- HOOK $0.95
- CCTG $1.13
- Average True Range (ATR)
- HOOK 0.06
- CCTG 0.04
- MACD
- HOOK -0.01
- CCTG 0.00
- Stochastic Oscillator
- HOOK 7.11
- CCTG 68.46
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. Its oncology portfolio targets oncoviral cancer antigens and next-generation antigens and includes two primary programs in development: eseba-vec (formerly HB-200) and HB-700. Eseba-vec is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers. It also develops infectious disease therapies in partnership with other companies. Its Hepatitis B (HBV) program, HB-400, and Human Immunodeficiency Virus (HIV) program, HB-500, are being developed in partnership with Gilead.
About CCTG CCSC Technology International Holdings Limited
CCSC Technology International Holdings Ltd along with its subsidiaries is involved in the sale, design, and manufacturing of interconnect products, including connectors, cables, and wire harnesses. Its products include customized interconnect products, including connectors, cables, and harnesses that are used for a range of applications in a diversified set of industries, including industrial, automotive, robotics, medical equipment, computer, network and telecommunication, and consumer products. Geographically, the company generates maximum revenue from the sale of its products in Europe and the rest from the Americas and Asia.